Kestra Advisory Services’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-44,500
| Closed | -$114K | – | 2943 |
|
|
2025
Q1 | $114K | Buy |
44,500
+30,500
| +218% | +$78.1K | ﹤0.01% | 2572 |
|
|
2024
Q4 | $26.3K | Sell |
14,000
-2,000
| -13% | -$3.76K | ﹤0.01% | 2618 |
|
|
2024
Q3 | $16.3K | Hold |
16,000
| – | – | ﹤0.01% | 2523 |
|
|
2024
Q2 | $18.7K | Hold |
16,000
| – | – | ﹤0.01% | 2584 |
|
|
2024
Q1 | $20.2K | Buy |
16,000
+4,500
| +39% | +$5.67K | ﹤0.01% | 2430 |
|
|
2023
Q4 | $20.5K | Hold |
11,500
| – | – | ﹤0.01% | 2246 |
|
|
2023
Q3 | $19.1K | Hold |
11,500
| – | – | ﹤0.01% | 2083 |
|
|
2023
Q2 | $23K | Buy |
+11,500
| New | +$23K | ﹤0.01% | 2075 |
|